IL-6 trans-signaling: an overlooked driver of retinal neovascularization?
IL-6 trans-signaling functions as an independent promoter of vitreoretinal vascular disease and therapeutic targeting of its pathway could beneficially complement current anti-VEGF treatment protocols.
Authors
- Günther Schlunck (ORCID: https://orcid.org/0000-0002-0355-7766)
- Luciana Hannibal (ORCID: https://orcid.org/0000-0002-0911-5758)
- Stefaniya Boneva (ORCID: https://orcid.org/0000-0002-9811-2160)
- Olaf Groß (ORCID: https://orcid.org/0000-0001-8660-3619)
- Melanie Schwämmle (ORCID: https://orcid.org/0000-0002-9040-3879)
- Felicitas Bucher (ORCID: https://orcid.org/0000-0003-0081-1420)
- Julian Rapp (ORCID: https://orcid.org/0000-0001-6770-8116)
- Jan Ness
- Malte Jung
- Hansjürgen Agostini
- Julia Mitschke
Institutions
- University of Freiburg (DE)
- University Medical Center Freiburg (DE)
- International Neuromodulation Society (US)
Publication Details
- Journal
- Angiogenesis
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1007/s10456-025-10022-8
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Albert-Ludwigs-Universität Freiburg